Advanced prostate cancer with ATM loss: PARP and ATR inhibitors
European Urology, November 2020
Activity of platinum-based chemotherapy in patients with advanced prostate cancer with and without DNA repair gene aberrations
JAMA Network Open, October 2020
Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer
BJU International, October 2020
Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1or BRCA2 gene alteration
Journal of Clinical Oncology, August 2020
Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise on oncologic efficacy: single-surgeon series and step-by-step guide
European Urology, June 2020
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
Annals of Oncology, May 2020
Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
Prostate Cancer and Prostatic Diseases, March 2020
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More